Walmart shares slide as U.S. sales hit by falling drug prices
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.
BELLINGS Intelligence Score: 15
Why it matters
Walmart's share decline due to lower drug prices and slower U.S. sales growth is a notable company-specific earnings update but does not materially affect credit markets or broader credit conditions.
Sources
MarketWatch
Walmart shares slide as U.S. sales hit by falling drug prices
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.